Nyrada Inc.

Nyrada Inc.verified

NYR.AX

Price:

$0.85

Market Cap:

$177.93M

Nyrada Inc., a pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular, neurodegenerative, and chronic inflammatory diseases. Its products in the drug development stage include PCSK9 inhibitor for the treatment of high blood LDL-cholesterol levels in patients poorly responsive to or unable to take statin drugs; a neuroprotectant drug to reduce the disability in patients with ischaemic stroke and traumatic brain injury; a drug to treat pain associated with peripheral nerve damage; and a drug to treat autoimmune diseases, such as psoriasis. The company has collaboration with Walter Reed Army Institute of Research and University of New ...[Read more]

Industry

Biotechnology

IPO Date

2020-01-15

Stock Exchange

ASX

Ticker

NYR.AX

The Enterprise Value as of December 2025 (TTM) for Nyrada Inc. (NYR.AX) is 175.00M

According to Nyrada Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 175.00M. This represents a change of 999.61% compared to the average of 15.91M of the last 4 quarters.

Nyrada Inc. (NYR.AX) Historical Enterprise Value (quarterly & annually)

How has NYR.AX Enterprise Value performed in the past?

The mean historical Enterprise Value of Nyrada Inc. over the last ten years is 19.21M. The current 175.00M Enterprise Value has changed 91.00% with respect to the historical average. Over the past ten years (40 quarters), NYR.AX's Enterprise Value was at its highest in in the June 2025 quarter at 47.38M. The Enterprise Value was at its lowest in in the December 2023 quarter at -1212338.60.

Quarterly (TTM)
Annual

Average

19.21M

Median

18.97M

Minimum

659.48K

Maximum

45.08M

Nyrada Inc. (NYR.AX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Nyrada Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 744.68%

Maximum Annual Enterprise Value = 45.08M

Minimum Annual Increase = -93.56%

Minimum Annual Enterprise Value = 659.48K

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202545.08M744.68%
20245.34M709.33%
2023659.48K-93.56%
202210.25M-56.60%
202123.61M64.64%
202014.34M-49.75%
201928.53M10.27%

Nyrada Inc. (NYR.AX) Average Enterprise Value

How has NYR.AX Enterprise Value performed in the past?

The current Enterprise Value of Nyrada Inc. (NYR.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

17.03M

5-year avg

16.99M

10-year avg

19.21M

Nyrada Inc. (NYR.AX) Enterprise Value vs. Peers

How is NYR.AX’s Enterprise Value compared to its peers?

Nyrada Inc.’s Enterprise Value is greater than Paradigm Biopharmaceuticals Limited (119.33M), greater than Starpharma Holdings Limited (150.10M), greater than AVITA Medical, Inc. (126.16M), greater than EMVision Medical Devices Ltd (150.62M), greater than Pacific Edge Limited (108.85M), greater than Island Pharmaceuticals Limited (116.53M), greater than Austco Healthcare Limited (132.95M), greater than Recce Pharmaceuticals Ltd (172.38M), greater than Actinogen Medical Limited (155.42M), greater than Biome Australia Limited (86.93M),

Build a custom stock screener for Nyrada Inc. (NYR.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nyrada Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nyrada Inc. (NYR.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nyrada Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Nyrada Inc.'s Enterprise Value?

What is the highest Enterprise Value for Nyrada Inc. (NYR.AX)?

What is the 3-year average Enterprise Value for Nyrada Inc. (NYR.AX)?

What is the 5-year average Enterprise Value for Nyrada Inc. (NYR.AX)?

How does the current Enterprise Value for Nyrada Inc. (NYR.AX) compare to its historical average?